These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8836976)

  • 21. High-resolution PET studies in Alzheimer's disease.
    Kumar A; Schapiro MB; Grady C; Haxby JV; Wagner E; Salerno JA; Friedland RP; Rapoport SI
    Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral blood flow and metabolic rate of oxygen, glucose, lactate, pyruvate, ketone bodies and amino acids.
    Lying-Tunell U; Lindblad BS; Malmlund HO; Persson B
    Acta Neurol Scand; 1981 Jun; 63(6):337-50. PubMed ID: 7324866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal study of cerebral blood flow in Alzheimer's disease using single photon emission tomography.
    Sachdev P; Gaur R; Brodaty H; Walker A; Meares S; Koder D; Haindl W
    Psychiatry Res; 1997 Feb; 68(2-3):133-41. PubMed ID: 9104760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET.
    Ishii K; Kitagaki H; Kono M; Mori E
    J Nucl Med; 1996 Jul; 37(7):1159-65. PubMed ID: 8965188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic aspects of Alzheimer's disease.
    Nagata K; Sato M; Satoh Y; Watahiki Y; Kondoh Y; Sugawara M; Box G; Wright D; Leung S; Yuya H; Shimosegawa E
    Ann N Y Acad Sci; 2002 Nov; 977():391-402. PubMed ID: 12480778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain oxidative energy and related metabolism, neuronal stress, and Alzheimer's disease: a speculative synthesis.
    Hoyer S
    J Geriatr Psychiatry Neurol; 1993; 6(1):3-13. PubMed ID: 8422269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease.
    Croteau E; Castellano CA; Richard MA; Fortier M; Nugent S; Lepage M; Duchesne S; Whittingstall K; Turcotte ÉE; Bocti C; Fülöp T; Cunnane SC
    J Alzheimers Dis; 2018; 64(2):551-561. PubMed ID: 29914035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease.
    Marcus DL; Freedman ML
    Ann N Y Acad Sci; 1997 Sep; 826():248-53. PubMed ID: 9329696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain energy metabolism in early blind subjects: neural activity in the visual cortex.
    De Volder AG; Bol A; Blin J; Robert A; Arno P; Grandin C; Michel C; Veraart C
    Brain Res; 1997 Mar; 750(1-2):235-44. PubMed ID: 9098549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent fasting and Alzheimer's disease-Targeting ketone bodies as a potential strategy for brain energy rescue.
    Ye YC; Chai SF; Li XR; Wu MN; Cai HY; Wang ZJ
    Metab Brain Dis; 2024 Jan; 39(1):129-146. PubMed ID: 37823968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis.
    Castro CB; Dias CB; Hillebrandt H; Sohrabi HR; Chatterjee P; Shah TM; Fuller SJ; Garg ML; Martins RN
    Nutr Rev; 2023 Aug; 81(9):1144-1162. PubMed ID: 36633304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?
    Hoyer S; Oesterreich K; Wagner O
    J Neurol; 1988 Jan; 235(3):143-8. PubMed ID: 3367161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypometabolism as a therapeutic target in Alzheimer's disease.
    Costantini LC; Barr LJ; Vogel JL; Henderson ST
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S16. PubMed ID: 19090989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial.
    Svart M; Gormsen LC; Hansen J; Zeidler D; Gejl M; Vang K; Aanerud J; Moeller N
    PLoS One; 2018; 13(2):e0190556. PubMed ID: 29489818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Energy metabolism in demented brain.
    Sorbi S; Fani C; Piacentini S; Giannini E; Amaducci L
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):591-7. PubMed ID: 3541053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.
    Cunnane SC; Courchesne-Loyer A; St-Pierre V; Vandenberghe C; Pierotti T; Fortier M; Croteau E; Castellano CA
    Ann N Y Acad Sci; 2016 Mar; 1367(1):12-20. PubMed ID: 26766547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral metabolic changes in Alzheimer's disease: neurobehavioral patterns.
    Blesa R; Mohr E; Miletich RS; Hildebrand K; Sampson M; Chase TN
    Dementia; 1996; 7(5):239-45. PubMed ID: 8872413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain glucose and ketone utilization in brain aging and neurodegenerative diseases.
    Kapogiannis D; Avgerinos KI
    Int Rev Neurobiol; 2020; 154():79-110. PubMed ID: 32739015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherent abnormalities in oxidative metabolism in Alzheimer's disease: interaction with vascular abnormalities.
    Blass JP; Sheu KF; Piacentini S; Sorbi S
    Ann N Y Acad Sci; 1997 Sep; 826():382-5. PubMed ID: 9329708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.